Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity.

Salati M, Baldessari C, Bonetti LR, Messina C, Merz V, Cerbelli B, Botticelli A.

Crit Rev Oncol Hematol. 2019 Nov 1;144:102826. doi: 10.1016/j.critrevonc.2019.102826. [Epub ahead of print] Review.

PMID:
31707223
2.

Adjuvant chemotherapy in resected bile duct cancer: A systematic review and meta-analysis of randomized trials.

Messina C, Merz V, Frisinghelli M, Trentin C, Grego E, Veccia A, Salati M, Messina M, Carnaghi C, Caffo O.

Crit Rev Oncol Hematol. 2019 Sep 9;143:124-129. doi: 10.1016/j.critrevonc.2019.09.002. [Epub ahead of print] Review.

PMID:
31563828
3.

Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer.

Santoro R, Zanotto M, Simionato F, Zecchetto C, Merz V, Cavallini C, Piro G, Sabbadini F, Boschi F, Scarpa A, Melisi D.

Mol Cancer Ther. 2019 Sep 27. pii: molcanther.0270.2019. doi: 10.1158/1535-7163.MCT-19-0270. [Epub ahead of print]

PMID:
31562256
4.

Population pharmacokinetics and exposure-overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer.

Gueorguieva I, Tabernero J, Melisi D, Macarulla T, Merz V, Waterhouse TH, Miles C, Lahn MM, Cleverly A, Benhadji KA.

Cancer Chemother Pharmacol. 2019 Nov;84(5):1003-1015. doi: 10.1007/s00280-019-03931-1. Epub 2019 Sep 3.

PMID:
31482224
5.

Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma.

Maggino L, Malleo G, Marchegiani G, Viviani E, Nessi C, Ciprani D, Esposito A, Landoni L, Casetti L, Tuveri M, Paiella S, Casciani F, Sereni E, Binco A, Bonamini D, Secchettin E, Auriemma A, Merz V, Simionato F, Zecchetto C, D'Onofrio M, Melisi D, Bassi C, Salvia R.

JAMA Surg. 2019 Jul 24. doi: 10.1001/jamasurg.2019.2277. [Epub ahead of print]

PMID:
31339530
6.

Zwitterion-Functionalized Detonation Nanodiamond with Superior Protein Repulsion and Colloidal Stability in Physiological Media.

Merz V, Lenhart J, Vonhausen Y, Ortiz-Soto ME, Seibel J, Krueger A.

Small. 2019 Jun 17:e1901551. doi: 10.1002/smll.201901551. [Epub ahead of print]

PMID:
31207085
7.

Tracking Five Millennia of Horse Management with Extensive Ancient Genome Time Series.

Fages A, Hanghøj K, Khan N, Gaunitz C, Seguin-Orlando A, Leonardi M, McCrory Constantz C, Gamba C, Al-Rasheid KAS, Albizuri S, Alfarhan AH, Allentoft M, Alquraishi S, Anthony D, Baimukhanov N, Barrett JH, Bayarsaikhan J, Benecke N, Bernáldez-Sánchez E, Berrocal-Rangel L, Biglari F, Boessenkool S, Boldgiv B, Brem G, Brown D, Burger J, Crubézy E, Daugnora L, Davoudi H, de Barros Damgaard P, de Los Ángeles de Chorro Y de Villa-Ceballos M, Deschler-Erb S, Detry C, Dill N, do Mar Oom M, Dohr A, Ellingvåg S, Erdenebaatar D, Fathi H, Felkel S, Fernández-Rodríguez C, García-Viñas E, Germonpré M, Granado JD, Hallsson JH, Hemmer H, Hofreiter M, Kasparov A, Khasanov M, Khazaeli R, Kosintsev P, Kristiansen K, Kubatbek T, Kuderna L, Kuznetsov P, Laleh H, Leonard JA, Lhuillier J, Liesau von Lettow-Vorbeck C, Logvin A, Lõugas L, Ludwig A, Luis C, Arruda AM, Marques-Bonet T, Matoso Silva R, Merz V, Mijiddorj E, Miller BK, Monchalov O, Mohaseb FA, Morales A, Nieto-Espinet A, Nistelberger H, Onar V, Pálsdóttir AH, Pitulko V, Pitskhelauri K, Pruvost M, Rajic Sikanjic P, Rapan Papeša A, Roslyakova N, Sardari A, Sauer E, Schafberg R, Scheu A, Schibler J, Schlumbaum A, Serrand N, Serres-Armero A, Shapiro B, Sheikhi Seno S, Shevnina I, Shidrang S, Southon J, Star B, Sykes N, Taheri K, Taylor W, Teegen WR, Trbojević Vukičević T, Trixl S, Tumen D, Undrakhbold S, Usmanova E, Vahdati A, Valenzuela-Lamas S, Viegas C, Wallner B, Weinstock J, Zaibert V, Clavel B, Lepetz S, Mashkour M, Helgason A, Stefánsson K, Barrey E, Willerslev E, Outram AK, Librado P, Orlando L.

Cell. 2019 May 30;177(6):1419-1435.e31. doi: 10.1016/j.cell.2019.03.049. Epub 2019 May 2.

8.

Author Correction: Ancient hepatitis B viruses from the Bronze Age to the Medieval period.

Muhlemann B, Jones TC, de Barros Damgaard P, Allentoft ME, Shevnina I, Logvin A, Usmanova E, Panyushkina IP, Boldgiv B, Bazartseren T, Tashbaeva K, Merz V, Lau N, Smrčka V, Voyakin D, Kitov E, Epimakhov A, Pokutta D, Vicze M, Price TD, Moiseyev V, Hansen AJ, Orlando L, Rasmussen S, Sikora M, Vinner L, Osterhaus ADME, Smith DJ, Glebe D, Fouchier RAM, Drosten C, Sjogren KG, Kristiansen K, Willerslev E.

Nature. 2018 Oct;562(7726):E4. doi: 10.1038/s41586-018-0406-6.

PMID:
30108364
9.

Ancient hepatitis B viruses from the Bronze Age to the Medieval period.

Mühlemann B, Jones TC, Damgaard PB, Allentoft ME, Shevnina I, Logvin A, Usmanova E, Panyushkina IP, Boldgiv B, Bazartseren T, Tashbaeva K, Merz V, Lau N, Smrčka V, Voyakin D, Kitov E, Epimakhov A, Pokutta D, Vicze M, Price TD, Moiseyev V, Hansen AJ, Orlando L, Rasmussen S, Sikora M, Vinner L, Osterhaus ADME, Smith DJ, Glebe D, Fouchier RAM, Drosten C, Sjögren KG, Kristiansen K, Willerslev E.

Nature. 2018 May;557(7705):418-423. doi: 10.1038/s41586-018-0097-z. Epub 2018 May 9. Erratum in: Nature. 2018 Oct;562(7726):E4.

PMID:
29743673
10.

The first horse herders and the impact of early Bronze Age steppe expansions into Asia.

de Barros Damgaard P, Martiniano R, Kamm J, Moreno-Mayar JV, Kroonen G, Peyrot M, Barjamovic G, Rasmussen S, Zacho C, Baimukhanov N, Zaibert V, Merz V, Biddanda A, Merz I, Loman V, Evdokimov V, Usmanova E, Hemphill B, Seguin-Orlando A, Yediay FE, Ullah I, Sjögren KG, Iversen KH, Choin J, de la Fuente C, Ilardo M, Schroeder H, Moiseyev V, Gromov A, Polyakov A, Omura S, Senyurt SY, Ahmad H, McKenzie C, Margaryan A, Hameed A, Samad A, Gul N, Khokhar MH, Goriunova OI, Bazaliiskii VI, Novembre J, Weber AW, Orlando L, Allentoft ME, Nielsen R, Kristiansen K, Sikora M, Outram AK, Durbin R, Willerslev E.

Science. 2018 Jun 29;360(6396). pii: eaar7711. doi: 10.1126/science.aar7711. Epub 2018 May 9.

11.

Ancient genomes revisit the ancestry of domestic and Przewalski's horses.

Gaunitz C, Fages A, Hanghøj K, Albrechtsen A, Khan N, Schubert M, Seguin-Orlando A, Owens IJ, Felkel S, Bignon-Lau O, de Barros Damgaard P, Mittnik A, Mohaseb AF, Davoudi H, Alquraishi S, Alfarhan AH, Al-Rasheid KAS, Crubézy E, Benecke N, Olsen S, Brown D, Anthony D, Massy K, Pitulko V, Kasparov A, Brem G, Hofreiter M, Mukhtarova G, Baimukhanov N, Lõugas L, Onar V, Stockhammer PW, Krause J, Boldgiv B, Undrakhbold S, Erdenebaatar D, Lepetz S, Mashkour M, Ludwig A, Wallner B, Merz V, Merz I, Zaibert V, Willerslev E, Librado P, Outram AK, Orlando L.

Science. 2018 Apr 6;360(6384):111-114. doi: 10.1126/science.aao3297. Epub 2018 Feb 22.

PMID:
29472442
12.

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.

Carbone C, Piro G, Merz V, Simionato F, Santoro R, Zecchetto C, Tortora G, Melisi D.

Int J Mol Sci. 2018 Feb 1;19(2). pii: E431. doi: 10.3390/ijms19020431. Review.

13.

Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling.

Carbone C, Piro G, Gaianigo N, Ligorio F, Santoro R, Merz V, Simionato F, Zecchetto C, Falco G, Conti G, Kamga PT, Krampera M, Di Nicolantonio F, De Franceschi L, Scarpa A, Tortora G, Melisi D.

Int J Obes (Lond). 2018 Mar;42(3):334-343. doi: 10.1038/ijo.2017.285. Epub 2017 Nov 20.

14.

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma.

Piro G, Simionato F, Carbone C, Frizziero M, Malleo G, Zanini S, Casolino R, Santoro R, Mina MM, Zecchetto C, Merz V, Scarpa A, Bassi C, Tortora G, Melisi D.

Oncoimmunology. 2017 Apr 28;6(9):e1322242. doi: 10.1080/2162402X.2017.1322242. eCollection 2017.

15.

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.

Carbone C, Piro G, Simionato F, Ligorio F, Cremolini C, Loupakis F, Alì G, Rossini D, Merz V, Santoro R, Zecchetto C, Zanotto M, Di Nicolantonio F, Bardelli A, Fontanini G, Tortora G, Melisi D.

Clin Cancer Res. 2017 Aug 1;23(15):4312-4322. doi: 10.1158/1078-0432.CCR-16-3153. Epub 2017 Mar 15.

16.

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.

Piro G, Carbone C, Cataldo I, Di Nicolantonio F, Giacopuzzi S, Aprile G, Simionato F, Boschi F, Zanotto M, Mina MM, Santoro R, Merz V, Sbarbati A, de Manzoni G, Scarpa A, Tortora G, Melisi D.

Clin Cancer Res. 2016 Dec 15;22(24):6164-6175. Epub 2016 Jun 7.

17.

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.

Piro G, Giacopuzzi S, Bencivenga M, Carbone C, Verlato G, Frizziero M, Zanotto M, Mina MM, Merz V, Santoro R, Zanoni A, De Manzoni G, Tortora G, Melisi D.

Br J Cancer. 2015 Sep 15;113(6):878-85. doi: 10.1038/bjc.2015.283. Epub 2015 Aug 20.

18.

Brief interventions to prevent recurrence and alcohol-related problems in young adults admitted to the emergency ward following an alcohol-related event: a systematic review.

Merz V, Baptista J, Haller DM.

J Epidemiol Community Health. 2015 Sep;69(9):912-7. doi: 10.1136/jech-2014-204824. Epub 2015 Apr 3. Review.

PMID:
25841242
19.

[Cancer of the prostate: importance of androgen deprivation and radiotherapy].

Rentsch CA, Aebersold DM, Merz V, Studer UE.

Rev Med Suisse. 2005 May 11;1(19):1303-6. Review. French. No abstract available.

PMID:
15962630
20.

TGF-beta 3 expression correlates with epithelial cell death in normal, hyperplastic and malignant prostate.

Djonov V, Andres A, Altermatt H, Merz V.

Int J Oncol. 1997 Dec;11(6):1185-90.

PMID:
21528320
21.

Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations.

Mottaz AE, Markwalder R, Fey MF, Klima I, Merz VW, Thalmann GN, Ball RK, Studer UE.

Prostate. 1997 Jun 1;31(4):209-15.

PMID:
9180930
22.
23.

No evidence of osteopenia 5 to 8 years after ileal orthotopic bladder substitution.

Tschopp AB, Lippuner K, Jaeger P, Merz VW, Danuser H, Studer UE.

J Urol. 1996 Jan;155(1):71-5.

PMID:
7490902
24.

Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment.

Studer UE, Danuser H, Merz VW, Springer JP, Zingg EJ.

J Urol. 1995 Jul;154(1):49-56.

PMID:
7776455
25.

Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guérin for carcinoma in situ of the bladder.

Merz VW, Marth D, Kraft R, Ackermann DK, Zingg EJ, Studer UE.

Br J Urol. 1995 Feb;75(2):180-4.

PMID:
7850322
26.

Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis.

Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, Flanders KC, Park SH, Thompson TC.

Endocrinology. 1994 Mar;134(3):1039-45.

PMID:
8119140
28.

Pseudoregression of pulmonary metastasis after nephrectomy for renal carcinoma.

Merz VW, Looser C, Kraft R, Studer UE.

Br J Urol. 1993 Jun;71(6):751-3. No abstract available.

PMID:
8343906
29.

Bladder substitutes made of crossfolded ileum.

Merz VW, Studer UE.

Scand J Urol Nephrol Suppl. 1992;142:100-4. Review. No abstract available.

PMID:
1496287
30.

Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.

Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, Thompson TC.

Mol Endocrinol. 1991 Apr;5(4):503-13.

PMID:
1922083
31.

Experimental oncogene induced prostate cancer.

Thompson TC, Kadmon D, Timme TL, Merz VW, Egawa S, Krebs T, Scardino PT, Park SH.

Cancer Surv. 1991;11:55-71.

PMID:
1726789
32.

[Clinical experiences with extracorporeal shockwave lithotripsy].

Ackermann D, Merz V, Marth D, Zehntner C.

Schweiz Med Wochenschr. 1989 Jul 1;119(26):935-40. German.

PMID:
2799324
33.

[Conservative treatment of splenic injuries in the adult].

Schneider RP, Merz V, Meuli R, Anderegg A, Preitner J, Mosimann R.

Helv Chir Acta. 1989 Jun;56(1-2):195-8. French.

PMID:
2674062
34.

Supplemental Content

Support Center